BR

Bebi Ramdas Jaykare

Active Director Director DIN 10060363
DIN 10060363 First appointment Mar 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Bebi Ramdas Jaykare

Data last updated:

Bebi Ramdas Jaykare is a Director at Nrj Pharmachem Private Limited (since 2023). The company operates in Pharma. Nrj Pharmachem Private Limited reported revenue of ₹4.95 Cr (FY 2025).

DIN 10060363
Primary Designation Director
Industry Pharma
First Appointment 03 Mar 2023
Oldest Company Age 11 yrs
Largest company Nrj Pharmachem Private Limited · ₹4.95 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nrj Pharmachem Private Limited U74999MH2015PTC269188
Director03 Mar 20232015₹4.95 Cr (FY 2025)Active

Board colleagues of Bebi Ramdas Jaykare

NameDINCompanyDesignation
Rita Jitendra Wankhede07286858Nrj Pharmachem Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nrj Pharmachem Private Limited
Premium access

Shareholding and investment profile for Bebi Ramdas Jaykare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bebi Ramdas Jaykare

Bebi Ramdas Jaykare currently holds 1 directorship: Nrj Pharmachem Private Limited (Director, since 03 Mar 2023, revenue ₹4.95 Cr (FY 2025)).

Bebi Ramdas Jaykare was first appointed on 03 Mar 2023 as Director at Nrj Pharmachem Private Limited.

The current boards of Bebi Ramdas Jaykare's companies include Rita Jitendra Wankhede (Nrj Pharmachem Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available